A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours
Titel:
A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours
Auteur:
Jamieson, David Griffin, Melanie J. Sludden, Julieann Drew, Yvette Cresti, Nicola Swales, Karen Merriman, Mark Allen, Rodger Bevan, Paul Buerkle, Markus Mala, Carola Coyle, Vicky Rodgers, Lisa Dean, Emma Greystoke, Alastair Banerji, Udai Wilson, Richard H. Evans, T.R. Jeffery Anthoney, Alan Ranson, Malcolm Boddy, Alan V. Plummer, Ruth